DarioHealth (NASDAQ:DRIO) Stock Price Passes Above 50 Day Moving Average – Here’s Why

Shares of DarioHealth Corp. (NASDAQ:DRIO) crossed above its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $0.68 and traded as high as $0.72. DarioHealth shares last traded at $0.72, with a volume of 94,056 shares.

Analyst Ratings Changes

Several equities analysts have issued reports on the company. Litchfield Hills Research initiated coverage on DarioHealth in a report on Monday, May 19th. They set a “buy” rating and a $3.00 price objective on the stock. TD Cowen cut DarioHealth from a “buy” rating to a “hold” rating and dropped their price target for the company from $2.00 to $1.00 in a research report on Wednesday, January 29th. Stifel Nicolaus dropped their price target on DarioHealth from $3.50 to $2.00 and set a “buy” rating on the stock in a research report on Tuesday, March 11th. Finally, Wall Street Zen cut DarioHealth from a “hold” rating to a “sell” rating in a research report on Thursday, May 22nd.

DarioHealth Price Performance

The stock has a market cap of $31.64 million, a price-to-earnings ratio of -0.77 and a beta of 1.55. The company has a 50-day moving average of $0.68 and a 200-day moving average of $0.72. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.32 and a current ratio of 1.57.

DarioHealth (NASDAQ:DRIO) last announced its quarterly earnings data on Wednesday, May 14th. The company reported ($0.14) EPS for the quarter, missing analysts’ consensus estimates of ($0.07) by ($0.07). The firm had revenue of $6.75 million during the quarter, compared to analyst estimates of $7.48 million. DarioHealth had a negative net margin of 205.62% and a negative return on equity of 72.16%. During the same quarter in the previous year, the business earned $0.05 EPS. As a group, equities research analysts predict that DarioHealth Corp. will post -1.18 earnings per share for the current year.

Institutional Investors Weigh In On DarioHealth

A hedge fund recently bought a new stake in DarioHealth stock. AMH Equity Ltd purchased a new stake in shares of DarioHealth Corp. (NASDAQ:DRIO) in the first quarter, according to its most recent filing with the SEC. The firm purchased 250,000 shares of the company’s stock, valued at approximately $153,000. AMH Equity Ltd owned 0.60% of DarioHealth at the end of the most recent quarter. 33.39% of the stock is owned by hedge funds and other institutional investors.

About DarioHealth

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.